Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03562871
Brief Title: IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

First Submitted : May 14, 2018
First Submitted that Met QC Criteria : June 8, 2018
First Posted : June 20, 2018

Last Update Submitted that Met QC Criteria : May 18, 2021
Last Update Posted : May 19, 2021